Tandem Diabetes Care (TNDM) Return on Capital Employed Growth (3y) (2017 - 2026)
Tandem Diabetes Care (TNDM) Return on Capital Employed Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -236.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 281.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 446.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -433.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1,627.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -62.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 370.00 |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | 2,481.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,481.00 |
| Mar 31, 2026 | 1,377.00 |
| Dec 31, 2025 | -1,899.00 |
| Sep 30, 2025 | -2,432.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | -2,843.00 |
| Dec 31, 2024 | -1,689.00 |
| Sep 30, 2024 | -2,347.00 |
| Jun 30, 2024 | -2,288.00 |
| Mar 31, 2024 | -1,989.00 |
| Dec 31, 2023 | -2,971.00 |
| Sep 30, 2023 | -2,402.00 |
| Jun 30, 2023 | -2,183.00 |
| Mar 31, 2023 | -1,646.00 |
| Dec 31, 2022 | -253.00 |
| Sep 30, 2022 | 337.00 |
| Jun 30, 2022 | 1,779.00 |
| Mar 31, 2022 | 3,127.00 |
| Dec 31, 2021 | 3,800.00 |
| Sep 30, 2021 | 5,330.00 |